{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:15Z","timestamp":1760144115554,"version":"build-2065373602"},"reference-count":74,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82101957","82271752","2022YFC2703400","2022YFC2703700"],"award-info":[{"award-number":["82101957","82271752","2022YFC2703400","2022YFC2703700"]}]},{"name":"National Key Research and Development Program of China","award":["82101957","82271752","2022YFC2703400","2022YFC2703700"],"award-info":[{"award-number":["82101957","82271752","2022YFC2703400","2022YFC2703700"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hemophilia A (HA) is a common X-linked recessive hereditary bleeding disorder. Coagulation factor VIII (FVIII) is insufficient in patients with HA due to the mutations in the F8 gene. The restoration of plasma levels of FVIII via both recombinant B-domain-deleted FVIII (BDD-FVIII) and B-domain-deleted F8 (BDDF8) transgenes was proven to be helpful. FVIII-Padua is a 23.4 kb tandem repeat mutation in the F8 associated with a high F8 gene expression and thrombogenesis. Here we screened a core enhancer element in FVIII-Padua for improving the F8 expression. In detail, we identified a 400 bp efficient enhancer element, C400, in FVIII-Padua for the first time. The core enhancer C400 extensively improved the transcription of BDDF8 driven by human elongation factor-1 alpha in HepG2, HeLa, HEK-293T and induced pluripotent stem cells (iPSCs) with different genetic backgrounds, as well as iPSCs-derived endothelial progenitor cells (iEPCs) and iPSCs-derived mesenchymal stem cells (iMSCs). The expression of FVIII protein was increased by C400, especially in iEPCs. Our research provides a novel molecular target to enhance expression of FVIII protein, which has scientific value and application prospects in both viral and nonviral HA gene therapy strategies.<\/jats:p>","DOI":"10.3390\/ijms25073635","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:47:11Z","timestamp":1711370831000},"page":"3635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of the Efficient Enhancer Elements in FVIII-Padua for Gene Therapy Study of Hemophilia A"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1929-0784","authenticated-orcid":false,"given":"Rou","family":"Xiao","sequence":"first","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Hu","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyu","family":"Tang","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-6000","authenticated-orcid":false,"given":"Miaojin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingqian","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-8585","authenticated-orcid":false,"given":"Desheng","family":"Liang","sequence":"additional","affiliation":[{"name":"Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/hae.14012","article-title":"The World Federation of Hemophilia Annual Global Survey 1999\u20132018","volume":"26","author":"Stonebraker","year":"2020","journal-title":"Haemophilia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ejh.13193","article-title":"Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients","volume":"102","author":"Ljung","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V81.11.2925.2925","article-title":"Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII","volume":"81","author":"Pittman","year":"1993","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nicholson, M.W., Ting, C.Y., Chan, D.Z.H., Cheng, Y.C., Lee, Y.C., Hsu, C.C., Huang, C.Y., and Hsieh, P.C.H. (2022). Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy. Cells, 11.","DOI":"10.3390\/cells11111853"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2019.05.019","article-title":"ssODN-Mediated In-Frame Deletion with CRISPR\/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs","volume":"17","author":"Hu","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.stemcr.2019.04.016","article-title":"Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR\/Cas9","volume":"12","author":"Park","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Qiu, L., Xie, M., Zhou, M., Liu, X., Hu, Z., and Wu, L. (2021). Restoration of FVIII Function and Phenotypic Rescue in Hemophilia a Mice by Transplantation of MSCs Derived from F8-Modified iPSCs. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.630353"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood.2020008168","article-title":"Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia","volume":"137","author":"Simioni","year":"2021","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, H., Chen, D., and Zhang, J. (2012). Analysis of intron sequence features associated with transcriptional regulation in human genes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046784"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature11232","article-title":"The accessible chromatin landscape of the human genome","volume":"489","author":"Thurman","year":"2012","journal-title":"Nature"},{"key":"ref_14","first-page":"1624","article-title":"Deciphering the Ets-1\/2-mediated transcriptional regulation of F8 gene identifies a minimal F8 promoter for hemophilia A gene therapy","volume":"106","author":"Borroni","year":"2021","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mvr.2016.02.004","article-title":"AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation","volume":"105","author":"Jia","year":"2016","journal-title":"Microvasc. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Norrman, K., Fischer, Y., Bonnamy, B., Wolfhagen Sand, F., Ravassard, P., and Semb, H. (2010). Quantitative comparison of constitutive promoters in human ES cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012413"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/scd.2007.0084","article-title":"Promoter-dependent EGFP expression during embryonic stem cell propagation and differentiation","volume":"17","author":"Wang","year":"2008","journal-title":"Stem Cells Dev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhao, J., Zhou, M., Wang, Z., Wu, L., Hu, Z., and Liang, D. (2022). Ectopic Expression of FVIII in HPCs and MSCs Derived from hiPSCs with Site-Specific Integration of ITGA2B Promoter-Driven BDDF8 Gene in Hemophilia A. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020623"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, X., Wu, Y., Li, Z., Yang, J., Xue, J., Hu, Y., Feng, M., Niu, W., Yang, Q., and Lei, M. (2012). Targeting of the human coagulation factor IX gene at rDNA locus of human embryonic stem cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037071"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2016.02.083","article-title":"Targeting of the human F8 at the multicopy rDNA locus in Hemophilia A patient-derived iPSCs using TALENickases","volume":"472","author":"Pang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhao, J., Duan, N., Liu, W., Zhang, Y., Zhou, M., Hu, Z., Feng, M., Liu, X., and Wu, L. (2018). Paired CRISPR\/Cas9 Nickases Mediate Efficient Site-Specific Integration of F9 into rDNA Locus of Mouse ESCs. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103035"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2014.02.099","article-title":"TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus","volume":"446","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbrc.2021.01.056","article-title":"Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs","volume":"545","author":"Zeng","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"40791","DOI":"10.18632\/oncotarget.16584","article-title":"Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/stcltm\/szab031","article-title":"Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy","volume":"11","author":"Wang","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.1038\/srep18865","article-title":"In situ genetic correction of F8 intron 22 inversion in Hemophilia A patient-specific iPSCs","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhou, M., Tang, S., Duan, N., Xie, M., Li, Z., Feng, M., Wu, L., Hu, Z., and Liang, D. (2022). Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147941"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3270","article-title":"Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A","volume":"19","author":"Pandey","year":"2013","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1538-7836.2005.01508.x","article-title":"Transplantation of endothelial cells corrects the phenotype in hemophilia A mice","volume":"3","author":"Kumaran","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"110621","DOI":"10.1016\/j.celrep.2022.110621","article-title":"Therapeutic correction of hemophilia A by transplantation of hPSC-derived liver sinusoidal endothelial cell progenitors","volume":"39","author":"Gage","year":"2022","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: The FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/01.ATV.20.12.2689","article-title":"Genetic induction of a releasable pool of factor VIII in human endothelial cells","volume":"20","author":"Rosenberg","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/stem.2577","article-title":"Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways","volume":"35","author":"Harding","year":"2017","journal-title":"Stem Cells"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"761616","DOI":"10.3389\/fimmu.2021.761616","article-title":"Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease","volume":"12","author":"Kelly","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13287-021-02265-1","article-title":"Mesenchymal stem\/stromal cells as a valuable source for the treatment of immune-mediated disorders","volume":"12","author":"Markov","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.biopha.2018.11.056","article-title":"Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran","volume":"109","author":"Ghoryani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2\u2212 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","article-title":"Mesenchymal stem\/stromal cells in cancer therapy","volume":"14","author":"Lan","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/jcp.24247","article-title":"Mesenchymal stem cells contribute to endogenous FVIII:c production","volume":"228","author":"Sanada","year":"2013","journal-title":"J. Cell Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Barbon, S., Stocco, E., Rajendran, S., Zardo, L., Macchi, V., Grandi, C., Tagariello, G., Porzionato, A., Radossi, P., and De Caro, R. (2022). In Vitro Conditioning of Adipose-Derived Mesenchymal Stem Cells by the Endothelial Microenvironment: Modeling Cell Responsiveness towards Non-Genetic Correction of Haemophilia A. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137282"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13287-019-1138-8","article-title":"Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells","volume":"10","author":"Gao","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13558","DOI":"10.1038\/s41598-017-13971-3","article-title":"Mesenchymal stem\/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts","volume":"7","author":"Shafiee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3324\/haematol.13427","article-title":"Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells","volume":"94","author":"Bouwens","year":"2009","journal-title":"Haematologica"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2014-07-588194","article-title":"AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice","volume":"125","author":"Crudele","year":"2015","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/bloodadvances.2017015313","article-title":"Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model","volume":"2","author":"French","year":"2018","journal-title":"Blood Adv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/hum.2014.106","article-title":"Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: Preclinical evaluation supporting an ongoing adeno-associated virus clinical trial","volume":"26","author":"Monahan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S2352-3026(22)00113-2","article-title":"Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: A single-centre, single-arm, phase 1, pilot trial","volume":"9","author":"Xue","year":"2022","journal-title":"Lancet Haematol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa2119913","article-title":"Phase 1\u20132 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B","volume":"387","author":"Chowdary","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant","volume":"377","author":"George","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Karabacak Calviello, A., Hirsekorn, A., Wurmus, R., Yusuf, D., and Ohler, U. (2019). Reproducible inference of transcription factor footprints in ATAC-seq and DNase-seq datasets using protocol-specific bias modeling. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1654-y"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1073\/pnas.92.14.6454","article-title":"Transcriptional activation of human adult alpha-globin genes by hypersensitive site-40 enhancer: Function of nuclear factor-binding motifs occupied in erythroid cells","volume":"92","author":"Rombel","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2011.01.024","article-title":"Functional and mechanistic diversity of distal transcription enhancers","volume":"144","author":"Bulger","year":"2011","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41592-021-01248-7","article-title":"Systematic evaluation of chromosome conformation capture assays","volume":"18","author":"Yang","year":"2021","journal-title":"Nat. Methods"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymeth.2020.03.005","article-title":"Methods for ChIP-seq analysis: A practical workflow and advanced applications","volume":"187","author":"Nakato","year":"2021","journal-title":"Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41592-020-0797-9","article-title":"Kethoxal-assisted single-stranded DNA sequencing captures global transcription dynamics and enhancer activity in situ","volume":"17","author":"Wu","year":"2020","journal-title":"Nat. Methods"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Hoerth, K., Reitter, S., and Schott, J. (2022). Normalized Ribo-Seq for Quantifying Absolute Global and Specific Changes in Translation. Bio Protoc., 12.","DOI":"10.21769\/BioProtoc.4323"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ingolia, N.T., Hussmann, J.A., and Weissman, J.S. (2019). Ribosome Profiling: Global Views of Translation. Cold Spring Harb. Perspect. Biol., 11.","DOI":"10.1101\/cshperspect.a032698"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41556-022-00928-6","article-title":"Ultrasensitive Ribo-seq reveals translational landscapes during mammalian oocyte-to-embryo transition and pre-implantation development","volume":"24","author":"Xiong","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1093\/hmg\/ddz157","article-title":"Advances and challenges for hemophilia gene therapy","volume":"28","author":"Batty","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1089\/hum.2021.29182.bfs","article-title":"Fourth Boy Dies in Clinical Trial of Astellas\u2019 AT132","volume":"32","author":"Philippidis","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2019003777","article-title":"Gene therapy for hemophilia: A review on clinical benefit, limitations, and remaining issues","volume":"138","author":"Leebeek","year":"2021","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1089\/hum.2017.255","article-title":"Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR\/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells","volume":"29","author":"Zhou","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_66","first-page":"299","article-title":"Stem Cell Therapy for Retinal Degeneration: The Evidence to Date","volume":"15","author":"Sharma","year":"2021","journal-title":"Biologics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.14348\/molcells.2021.0078","article-title":"iPSC-Derived Natural Killer Cells for Cancer Immunotherapy","volume":"44","author":"Karagiannis","year":"2021","journal-title":"Mol. Cells"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.blre.2017.07.001","article-title":"To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity","volume":"31","author":"Hartholt","year":"2017","journal-title":"Blood Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"848833","DOI":"10.3389\/fvets.2022.848833","article-title":"Production of Triple-Gene (GGTA1, B2M and CIITA)-Modified Donor Pigs for Xenotransplantation","volume":"9","author":"Xu","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/biot.201400666","article-title":"Industrial production of clotting factors: Challenges of expression, and choice of host cells","volume":"10","author":"Kumar","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt.3677","article-title":"Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction","volume":"35","author":"Zakas","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_74","first-page":"269","article-title":"The transcription factor LSF: A novel oncogene for hepatocellular carcinoma","volume":"2","author":"Santhekadur","year":"2012","journal-title":"Am. J. Cancer Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:17:53Z","timestamp":1760105873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/7\/3635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["ijms25073635"],"URL":"https:\/\/doi.org\/10.3390\/ijms25073635","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,3,24]]}}}